Study: Denying anti-depressants for teens, young adults raises risk of suicides
Government warnings a decade ago about the risks associated with children and adolescents taking anti-depressants, such as Paxil and Zoloft, appear to have backfired — causing an increase in suicide attempts and discouraging many depressed young people from seeking treatment, according to a study published on Wednesday.
Because of FDA warnings about SSRIs — selective serotonin reuptake inhibitors — anti-depressant prescriptions fell sharply for adolescents ages 10 to 17 and for young adults ages 18 to 29. At the same time, researchers found that the number of suicide attempts rose by more than 20 percent in adolescents and by more than a third in young adults.
Show commenting policy
TribLive commenting policy
- Report: Major changes needed for nation’s power infrastructure
- Residents near N.C. ash dumps told not to drink well water
- Pope accepts resignation of bishop in Kansas City, Mo. who failed to report suspected child abuser
- Pope accepts resignation of U.S. bishop who failed to report abuse
- Reagan shooter Hinckley closer to permanent freedom
- Federal appeals court appears divided on Obama’s immigrant deportation shield
- Missouri town, new mayor grapple with mass resignations
- Baltimore on edge over man’s fatal spine injury while in custody
- Minnesota Somali men foiled in plot to join terrorists in Syria
- Wis. resident dies in crash on way to birth of 8th child
- Sunken carrier used in atomic bomb tests found off Calif.